Table 5 Medications received by the study population
From: Risk factors and outcome of patients with eclampsia at a tertiary hospital in Egypt
| Â | Number | Percentage |
|---|---|---|
Magnesium sulphate | 250 | 100% |
Anti-hypertensive therapy: | ||
 -Oral nifidepine | 155 | 62% |
 -Oral labetalol | 23 | 9.2% |